Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026)

Insmed (INSM) recorded quarterly Change in Acquisitions & Divestments of $284.0 million in Q1 2026, down 34.86% quarter-over-quarter from $436.0 million in Q4 2025, and down 60.61% on a YoY basis from $721.0 million in Q1 2025.

Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Insmed's Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $284.0 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 60.61% year-over-year to $284.0 million; the TTM figure through Mar 2026 stood at $1.7 billion (up 15.03% YoY), while the FY2025 annual figure was $2.1 billion, up 105.71% from the prior year.
  • Change in Acquisitions & Divestments was $284.0 million for Q1 2026 at Insmed, down from $436.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $721.0 million in Q1 2025 to a low of $10.0 million in Q3 2023.
  • Historically, Change in Acquisitions & Divestments has averaged $295.4 million across 5 years, with a median of $300.0 million in 2023.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 1100.0% in 2023; the steepest drop was 80.0% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $25.0 million in 2022, then jumped by 1100.0% to $300.0 million in 2023, then soared by 138.67% to $716.0 million in 2024, then tumbled by 39.11% to $436.0 million in 2025, then plunged by 34.86% to $284.0 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $284.0 million (Q1 2026), $436.0 million (Q4 2025), and $425.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 284.00 Mn
Mar 31, 2026 284.00 Mn
Dec 31, 2025 436.00 Mn
Dec 31, 2025 436.00 Mn
Sep 30, 2025 425.00 Mn
Sep 30, 2025 425.00 Mn
Jun 30, 2025 508.00 Mn
Jun 30, 2025 508.00 Mn
Mar 31, 2025 721.00 Mn
Mar 31, 2025 721.00 Mn
Dec 31, 2024 716.00 Mn
Dec 31, 2024 716.00 Mn
Mar 31, 2024 300.00 Mn
Mar 31, 2024 300.00 Mn
Dec 31, 2023 300.00 Mn
Dec 31, 2023 300.00 Mn
Sep 30, 2023 10.00 Mn
Sep 30, 2023 10.00 Mn
Jun 30, 2023 20.00 Mn
Jun 30, 2023 20.00 Mn